Progyny (NASDAQ:PGNY) Upgraded to “Buy” at BTIG Research
Progyny (NASDAQ:PGNY – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a research report issued on Monday,Benzinga reports. The firm currently has a $28.00 target price on the stock. BTIG Research’s target price points to a potential upside of 21.26% from the stock’s […]
Progyny (NASDAQ:PGNY – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a research report issued on Monday,Benzinga reports. The firm currently has a $28.00 target price on the stock. BTIG Research’s target price points to a potential upside of 21.26% from the stock’s […]
